X4 Pharmaceuticals Inc (NASDAQ: XFOR) kicked off on Tuesday, down -4.86% from the previous trading day, before settling in for the closing price of $0.64. Over the past 52 weeks, XFOR has traded in a range of $0.53-$1.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -20.00% over the past five years. While this was happening, its average annual earnings per share was recorded 80.70%. With a float of $117.76 million, this company’s outstanding shares have now reached $167.43 million.
Let’s look at the performance matrix of the company that is accounted for 93 employees.
X4 Pharmaceuticals Inc (XFOR) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of X4 Pharmaceuticals Inc is 30.11%, while institutional ownership is 39.53%. The most recent insider transaction that took place on Mar 11 ’24, was worth 46,347. In this transaction Chief Financial Officer of this company sold 52,500 shares at a rate of $0.88, taking the stock ownership to the 0 shares. Before that another transaction happened on Mar 11 ’24, when Company’s President and CEO sold 49,678 for $0.88, making the entire transaction worth $43,856. This insider now owns 765,068 shares in total.
X4 Pharmaceuticals Inc (XFOR) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 80.70% per share during the next fiscal year.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Trading Performance Indicators
Take a look at X4 Pharmaceuticals Inc’s (XFOR) current performance indicators. Last quarter, stock had a quick ratio of 6.04. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 182.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.09, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of X4 Pharmaceuticals Inc (XFOR)
X4 Pharmaceuticals Inc (NASDAQ: XFOR) saw its 5-day average volume 1.26 million, a negative change from its year-to-date volume of 2.44 million. As of the previous 9 days, the stock’s Stochastic %D was 9.60%. Additionally, its Average True Range was 0.06.
During the past 100 days, X4 Pharmaceuticals Inc’s (XFOR) raw stochastic average was set at 6.91%, which indicates a significant increase from 1.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 76.56% in the past 14 days, which was lower than the 109.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8063, while its 200-day Moving Average is $0.9095. Nevertheless, the first resistance level for the watch stands at $0.6296 in the near term. At $0.6541, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.6683. If the price goes on to break the first support level at $0.5909, it is likely to go to the next support level at $0.5767. The third support level lies at $0.5522 if the price breaches the second support level.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Key Stats
The company with the Market Capitalisation of 101.94 million has total of 167,938K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -101,170 K annual income. Company’s last quarter sales were recorded 560 K and last quarter income was 90,830 K.
